191 related articles for article (PubMed ID: 2733275)
21. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
22. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
24. Management of operable breast cancer: the surgeon's view.
Urban JA
Cancer; 1978 Oct; 42(4):2066-77. PubMed ID: 101302
[TBL] [Abstract][Full Text] [Related]
25. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
26. Total number of lymph nodes and number of metastatic lymph nodes harvested during radical mastectomy did not influence early postoperative drainage volume.
Wysocki WM; Burzyński T; Stelmach A; Blecharz P; Mituś JW; Wysocka J; Komorowski AL
Ginekol Pol; 2013 Aug; 84(8):696-9. PubMed ID: 24191503
[TBL] [Abstract][Full Text] [Related]
27. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
29. Surgical clinical trials.
Donegan WL
Cancer; 1984 Feb; 53(3 Suppl):691-9. PubMed ID: 6362822
[TBL] [Abstract][Full Text] [Related]
30. [Changes in radical surgery of breast carcinoma in the last 20 years].
Mättig H; Stubert B; Schmerler R
Zentralbl Chir; 1997; 122(2):92-6. PubMed ID: 9173764
[TBL] [Abstract][Full Text] [Related]
31. [A role of interpectoral (Rotter's) lymph node dissection in modified radical mastectomy for breast cancer].
Yamasaki N; Kodama H
Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1427-32. PubMed ID: 1448050
[TBL] [Abstract][Full Text] [Related]
32. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
34. The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy.
Winchester DJ; Menck HR; Winchester DP
Cancer; 1997 Jul; 80(1):162-7. PubMed ID: 9210722
[TBL] [Abstract][Full Text] [Related]
35. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
Strom EA; Woodward WA; Katz A; Buchholz TA; Perkins GH; Jhingran A; Theriault R; Singletary E; Sahin A; McNeese MD
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1508-13. PubMed ID: 16169678
[TBL] [Abstract][Full Text] [Related]
36. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?
Freedman GM; Fowble BL; Nicolaou N; Sigurdson ER; Torosian MH; Boraas MC; Hoffman JP
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):805-14. PubMed ID: 10705000
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
38. [The range of removing fatty tissue and lymph nodes by a modified radical mastectomy with preservation of the major and minor pectoral muscles].
Kanai T
Nihon Geka Gakkai Zasshi; 1983 Feb; 84(2):103-12. PubMed ID: 6325863
[TBL] [Abstract][Full Text] [Related]
39. Lymph-node staining with activated carbon CH40: a new method for axillary lymph-node dissection in breast cancer.
Yokota T; Saito T; Narushima Y; Iwamoto K; Iizuka M; Hagiwara A; Sawai K; Kikuchi S; Kunii Y; Yamauchi H
Can J Surg; 2000 Jun; 43(3):191-6. PubMed ID: 10851412
[TBL] [Abstract][Full Text] [Related]
40. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]